GSK plc 4
4 · Wave Life Sciences Ltd. · Filed Oct 1, 2024
Insider Transaction Report
Form 4
GLAXOSMITHKLINE PLC
10% Owner
Transactions
- Purchase
Ordinary Shares
2024-09-27$8.00/sh+2,791,930$22,335,440→ 16,775,691 total(indirect: By Corporation)
Footnotes (1)
- [F1]The shares reported herein are held of record by Glaxo Group Limited, a wholly-owned subsidiary of GSK plc (the "Reporting Person").